Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

SHE/300702 stock hub

SHE/300702 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHE/300702is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

7.2B

Shenzhen Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHE/300702

In the news

Latest news · SHE/300702

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E23

P25 17.1P50 24.2P75 37.8

Trailing P/E74.4

P25 23.5P50 41.3P75 83.2

ROE2.6

P25 -0.9P50 4.1P75 8.8

ROIC4.8

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHE/300702 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

223

Groups with data

Currency

CNY

Showing 223 of 223 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	4,532
Employees Change	-158%
Employees Change Percent	-3.37
Enterprise value	CNY 8.4B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CNE1000034X1
Last refreshed	2026-05-10
Market cap	CNY 7.2B
Price	CNY 20.89
Price currency	CNY
Rev Per Employee	686,998.46x
Sector	Healthcare
Sic	2833
Symbol	she/300702
Website	https://www.tianyupharm.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.33%
EV Earnings	87.66x
EV/EBIT	31.45x
EV/EBITDA	13.16x
EV/FCF	38.24x
EV/Sales	2.7x
FCF yield	3.05%
Forward P/E	22.96x
P/B ratio	1.95x
P/E ratio	74.38x
P/S ratio	2.31x
PE Ratio10 Y	78.95x
PE Ratio3 Y	146.17x
PE Ratio5 Y	125.42x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	8.57%
EBITDA Margin	19.99%
FCF margin	7.05%
Gross margin	35.81%
Gross Profit	CNY 1.1B
Gross Profit Growth	17.11%
Gross Profit Growth Q	-7.24%
Gross Profit Growth3 Y	20.26%
Gross Profit Growth5 Y	-3.21%
Net Income	CNY 95.7M
Net Income Growth	-5.79%
Net Income Growth Q	-51.05%
Net Income Growth Years	3%
Net Income Growth5 Y	-31.49%
Pretax Margin	3.5%
Profit Margin	3.07%
Profit Per Employee	CNY 21,121
Profitable Years	3
ROA	2.58
Roa5y	1.35
ROCE	6.7
ROE	2.63
Roe5y	1.73
ROIC	4.78
Roic5y	2.4

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-2.16%
Cagr3y	-7.89%
Cagr5y	-10.66%
Div CAGR3	-20.63%
Div CAGR5	-29.03%
EPS Growth	-3.37
EPS Growth Q	-51.07
EPS Growth Years	3
EPS Growth5 Y	-31.83
FCF Growth	142.99%
OCF Growth	125.35%
OCF Growth Q	738.73%
OCF Growth3 Y	144.06%
OCF Growth5 Y	10.07%
Revenue Growth	15.29x
Revenue Growth Q	6.89x
Revenue Growth Quarters	8x
Revenue Growth Years	2x
Revenue Growth3 Y	4.94x
Revenue Growth5 Y	2.31x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.48
Assets	CNY 6.4B
Cash	CNY 572.5M
Current Assets	CNY 2.9B
Current Liabilities	CNY 2.5B
Debt	CNY 1.8B
Debt EBITDA	CNY 2.79
Debt Equity	CNY 0.48
Debt FCF	CNY 8.11
Equity	CNY 3.7B
Liabilities	CNY 2.8B
Long Term Assets	CNY 3.5B
Long Term Liabilities	CNY 302.4M
Net Cash	CNY -1.2B
Net Cash By Market Cap	CNY -16.79
Net Debt EBITDA	CNY 1.94
Net Debt Equity	CNY 0.33
Net Debt FCF	CNY 5.5
Tangible Book Value	CNY 3.2B
Tangible Book Value Per Share	CNY 9.28
WACC	5.41

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.19
Inventory Turnover	1.18
Net Working Capital	CNY 1.5B
Quick ratio	0.52
Working Capital	CNY 464.4M
Working Capital Turnover	CNY 7.39

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	2.5%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	CNY 0.05
Dividend Years	2
Dividend Yield	0.24%
Last Dividend	CNY 0.05
Payout Ratio	17.8%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-2.15%
200-day SMA	24.86
3Y total return	-21.85%
50-day SMA	22.55
50-day SMA vs 200-day SMA	50under200
5Y total return	-43.08%
All Time High	72.02
All Time High Change	-70.99%
All Time High Date	2020-08-31
All Time Low	7.51
All Time Low Change	178.16%
All Time Low Date	2018-10-19
ATR	0.71
Beta	0.45
Beta1y	0.55
Beta2y	0.71
Ch YTD	-11.48
High	21.25
High52	31.2
High52 Date	2025-08-11
High52ch	-33.04%
Low	20.51
Low52	20.2
Low52 Date	2026-03-23
Low52ch	3.42%
Ma50ch	-7.37%
Price vs 200-day SMA	-15.98%
RSI	36.21
RSI Monthly	44.86
RSI Weekly	37.33
Sharpe ratio	0.17x
Sortino ratio	0.45
Total Return	2.74%
Tr YTD	-11.48
Tr1m	-7.57%
Tr1w	1.02%
Tr3m	-18.4%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 266.8M
Operating Income Growth	33.13
Operating Income Growth Q	-26.14
Operating Income Growth5 Y	-17.1
Operating margin	8.57

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	157,646,569%
Net Borrowing	-53,280,069
Shares Insiders	52.99%
Shares Institutions	13.13%
Shares Out	343,927,096
Shares Qo Q	11.94%
Shares Yo Y	-2.5%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY 219.4M
Average Volume	3,404,844.2x
Bv Per Share	10.58
CAPEX	CNY -369.2M
Ch1m	-7.57
Ch1w	1.02
Ch1y	-2.34
Ch3m	-18.4
Ch3y	-22.2
Ch5y	-43.9
Ch6m	-17.07
Change	1.36%
Change From Open	1.11
Close	20.61
Days Gap	0.24
Depreciation Amortization	355,436,379
Dollar Volume	87,028,157.8
Earnings Date	2026-04-24
EBIT	CNY 266.8M
EBITDA	CNY 622.2M
EPS	CNY 0.28
F Score	7
FCF	CNY 219.4M
FCF EV Yield	2.62x
FCF Per Share	CNY 0.64
Financing CF	-113,063,142
Fiscal Year End	December
Founded	1,993
Graham Number	8.17574
Graham Upside	-60.86
Income Tax	CNY 13.4M
Investing CF	-383,313,581
Is Primary Listing	1
Last Earnings Date	2026-04-24
Last Report Date	2026-03-31
Last Split Date	2021-06-18
Last Split Type	Forward
Lynch Fair Value	CNY 1.4
Lynch Upside	-93.28
Ma150	24.29
Ma150ch	-14%
Ma20	22.09
Ma20ch	-5.44%
Net CF	77,433,840
Next Earnings Date	2026-08-21
Open	20.66
P FCF Ratio	32.74
P OCF Ratio	12.21
Payment Date	2025-06-06
Position In Range	51.35
Ppne	2,867,798,198
Price Date	2026-05-08
Price EBITDA	CNY 11.55
Ptbv Ratio	2.22
Relative Volume	1.28x
Revenue	3,113,477,017x
Tax By Revenue	0.43x
Tax Rate	12.27%
Tr6m	-17.07%
Volume	4,166,020

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHE/300702 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.2%

$0.05 annual per share

Payout ratio

+17.8%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-29.0%

0 consecutive years of growth

Total shareholder yield

+2.7%

Dividend yield + buyback yield combined

Performance

SHE/300702 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHE/300702?

Insider, institutional, and short-interest positioning.

Institutional ownership

+13.1%

Share of float held by funds and institutions

Insider ownership

+53.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-2.5%

Negative means the company is buying back shares.

Technical

SHE/300702 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

36.2

Neutral momentum band

Price vs 200-day MA

-16.0%

50/200-day relationship not available

Beta (5Y)

0.45

Less volatile than the market

Sharpe ratio

0.17

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHE/300702

Hub-level FAQ points readers to the deeper analysis pages.

What is the current she/300702 stock rating?

she/300702 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full she/300702 analysis?

The full report lives at /stocks/she/300702/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for she/300702?

The latest report frames she/300702 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the she/300702 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.